Deksmedetomidin Pliva 100 mikrograma/ml koncentrat za otopinu za infuziju
Name | Deksmedetomidin Pliva 100 mikrograma/ml koncentrat za otopinu za infuziju |
---|---|
Marketing Authorisation Number | HR-H-164413909 |
Active Substance | deksmedetomidinklorid |
Composition | jedan ml koncentrata sadrži deksmedetomidinklorid što odgovara 100 mikrograma deksmedetomidina |
Pharmaceutical Form | koncentrat za otopinu za infuziju |
Manufacturer | Teva Pharma B.V., Haarlem, Nizozemska Pliva Hrvatska d.o.o., Zagreb, Hrvatska |
Marketing Authorisation Holder | Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska |
Marketing Authorisation Date | 19.01.2022 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/21-02/14 |
Registration Number | 381-12-01/70-22-05 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | N05CM18 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o povećanom riziku od smrtnosti u bolesnika u dobi 65 godina i mlađih, vezano uz primjenu lijekova koji sadrže deksmedetomidin na jedinicama intenzivnog liječenja | 15.06.2022 | EVER Valinject GmbH, AS Kalceks, Mylan Ireland Limited, Pliva Hrvatska d.o.o., Orion Corporation, Accord Healthcare S.L.U. |